The Patent Finder

Myelos Corporation

Also on record
Records under this name other than patents Myelos Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Myelos Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,524,818Prosaposin as a Neurotrophic Factor
No holder on record
Term ended
Term ended Jul 20, 2016 · Medium confidence
Term endedTerm ended Jul 20, 2016Medium confidence
US 8,063,016Retro-inverso peptides derived from interleukin-6
Lapsed on the fee record
Ended Nov 22, 2015 · USPTO record
Lapsed on the fee recordEnded Nov 22, 2015USPTO record
US 6,590,074Prosaposin receptor
Lapsed on the fee record
Ended Jul 8, 2015 · USPTO record
Lapsed on the fee recordEnded Jul 8, 2015USPTO record
US 7,135,461Retro-inverso peptides derived from interleukin-6
Lapsed on the fee record
Ended Nov 14, 2014 · USPTO record
Lapsed on the fee recordEnded Nov 14, 2014USPTO record
US 7,115,571Retro-inverso peptides derived from interleukin-3
Lapsed on the fee record
Ended Oct 3, 2014 · USPTO record
Lapsed on the fee recordEnded Oct 3, 2014USPTO record
US 6,458,357Retro-inverso neurotrophic and analgesic peptides
Lapsed on the fee record
Ended Oct 1, 2014 · USPTO record
Lapsed on the fee recordEnded Oct 1, 2014USPTO record
US 7,109,168Retro-inverso peptides derived from leukemia inhibitory factor
Lapsed on the fee record
Ended Sep 19, 2014 · USPTO record
Lapsed on the fee recordEnded Sep 19, 2014USPTO record
US 7,754,688Methods of using retro-inverso peptides derived from interleukin-6
Lapsed on the fee record
Ended Jul 13, 2014 · USPTO record
Lapsed on the fee recordEnded Jul 13, 2014USPTO record
US 7,754,690Method of using retro inverso peptides derived from leukemia inhibitory factor
Lapsed on the fee record
Ended Jul 13, 2014 · USPTO record
Lapsed on the fee recordEnded Jul 13, 2014USPTO record
US 6,559,124Use of prosaposin and peptides obtained therefrom for treatment of neural degeneration
Term ended
Ended no later than Jul 30, 2013 · USPTO record
Term endedEnded no later than Jul 30, 2013USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited